Ciprofloxacin
(DIOIOSKKIYDRIQ-UHFFFAOYSA-N)
Structure
- SMILES
- Fc1cc2c(cc1N1CCNCC1)n(cc(c2=O)C(=O)O)C1CC1.Cl
- Molecular Formula:
- C17H19ClFN3O3
- Molecular Weight:
- 367.802
- Log P:
- 2.7791
- Hydrogen Bond Acceptor:
- 6
- Hydrogen Bond Donor:
- 3
- TPSA:
- 74.57
- CAS Number(s):
- 86483-48-9; 93107-08-5
Synonym(s)
1.
Ciprofloxacin
2.
Bay-09867
3.
Ciprinol
4.
Cipro
5.
Ciprofloxacin Hydrochloride
6.
Ciprofloxacin Hydrochloride Anhydrous
7.
Ciprofloxacin Monohydrochloride Monohydrate
8.
Anhydrous, Ciprofloxacin Hydrochloride
9.
Bay 09867
10.
Bay09867
11.
Hydrochloride Anhydrous, Ciprofloxacin
12.
Hydrochloride, Ciprofloxacin
13.
Monohydrate, Ciprofloxacin Monohydrochloride
14.
Monohydrochloride Monohydrate, Ciprofloxacin
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Arthralgia | FAERS: 180 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 2 | Dizziness | FAERS: 76 | US FAERS | |
| 3 | Pain | FAERS: 64 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 4 | Myalgia | FAERS: 61 | US FAERS | |
| 5 | Anxiety | FAERS: 56 | US FAERS | |
| 6 | Fatigue | FAERS: 55 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 7 | Headache | FAERS: 55 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 8 | Nausea | FAERS: 54 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 9 | Musculoskeletal Pain | FAERS: 40 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 10 | Asthenia | FAERS: 39 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 11 | Joint swelling | FAERS: 39 | US FAERS | |
| 12 | Back Pain | FAERS: 38 | US FAERS | |
| 13 | Burning sensation | FAERS: 37 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 14 | Tinnitus | FAERS: 35 | US FAERS | |
| 15 | Abasia | FAERS: 33 | US FAERS | |
| 16 | Feeling abnormal | FAERS: 33 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 17 | Tremor | FAERS: 32 | US FAERS | |
| 18 | Vomiting | FAERS: 31 | US FAERS | |
| 19 | Palpitations | FAERS: 28 | US FAERS | |
| 20 | Abdominal Pain | FAERS: 22 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 21 | Urticaria | FAERS: 22 | US FAERS | |
| 22 | Malaise | FAERS: 21 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 23 | Musculoskeletal stiffness | FAERS: 21 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 24 | Hypersensitivity | FAERS: 20 | US FAERS | |
| 25 | Neck Pain | FAERS: 20 | US FAERS | |
| 26 | Pruritus | FAERS: 20 | US FAERS | |
| 27 | Activities of daily living impaired | FAERS: 18 | US FAERS | |
| 28 | Joint stiffness | FAERS: 18 | US FAERS | |
| 29 | Visual Impairment | FAERS: 17 | US FAERS | |
| 30 | Chest Pain | FAERS: 16 | US FAERS | |
| 31 | Erythema | FAERS: 14 | US FAERS | |
| 32 | Inflammation | FAERS: 14 | US FAERS | |
| 33 | Nervousness | FAERS: 14 | US FAERS | |
| 34 | Neuralgia | FAERS: 14 | US FAERS | |
| 35 | Weight decreased | FAERS: 14 | US FAERS | |
| 36 | Arthropathy | FAERS: 13 | US FAERS | |
| 37 | Impaired work ability | FAERS: 13 | US FAERS | |
| 38 | Bone pain | FAERS: 12 | US FAERS | |
| 39 | Muscle tightness | FAERS: 12 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 40 | No adverse event | FAERS: 12 | US FAERS | |
| 41 | Abdominal discomfort | FAERS: 11 | US FAERS | |
| 42 | Arthritis | FAERS: 11 | US FAERS | |
| 43 | Swelling | FAERS: 11 | US FAERS | |
| 44 | Disorientation | FAERS: 10 | US FAERS | |
| 45 | Rotator cuff syndrome | FAERS: 10 | US FAERS | |
| 46 | Drug ineffective | FAERS: 9 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 47 | Eye pain | FAERS: 8 | US FAERS | |
| 48 | Flushing | FAERS: 8 | US FAERS | |
| 49 | Ligament rupture | FAERS: 8 | US FAERS | |
| 50 | Musculoskeletal discomfort | FAERS: 8 | US FAERS | |
| 51 | Toxicity to various agents | FAERS: 8 | US FAERS | |
| 52 | Unevaluable event | FAERS: 8 | US FAERS | |
| 53 | Vertigo | FAERS: 8 | US FAERS | |
| 54 | Agitation | FAERS: 7 | US FAERS | |
| 55 | Cerebrovascular accident | FAERS: 7 | US FAERS | |
| 56 | Chest discomfort | FAERS: 7 | US FAERS | |
| 57 | Chills | FAERS: 7 | US FAERS | |
| 58 | Feeling Cold | FAERS: 7 | US FAERS | |
| 59 | General physical health deterioration | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 60 | Memory impairment | FAERS: 7 | US FAERS | |
| 61 | Nerve injury | FAERS: 7 | US FAERS | |
| 62 | Photophobia | FAERS: 7 | US FAERS | |
| 63 | Restlessness | FAERS: 7 | US FAERS | |
| 64 | Syncope | FAERS: 7 | US FAERS | |
| 65 | Urinary tract infection | FAERS: 7 | US FAERS | |
| 66 | nervous system disorder | FAERS: 7 | US FAERS | |
| 67 | Dehydration | FAERS: 6 | US FAERS | |
| 68 | Dysgeusia | FAERS: 6 | US FAERS | |
| 69 | Dyspepsia | FAERS: 6 | US FAERS | |
| 70 | Emotional disorder | FAERS: 6 | US FAERS | |
| 71 | Hyperventilation | FAERS: 6 | US FAERS | |
| 72 | Joint Range of Motion Decreased | FAERS: 6 | US FAERS | |
| 73 | Joint injury | FAERS: 6 | US FAERS | |
| 74 | Vasculitis | FAERS: 6 | US FAERS | |
| 75 | Walking aid user | FAERS: 6 | US FAERS | |
| 76 | Blood creatinine increased | FAERS: 5 | US FAERS | |
| 77 | Clostridium difficile colitis | FAERS: 5 | US FAERS | |
| 78 | Constipation | FAERS: 5 | US FAERS | |
| 79 | Crying | FAERS: 5 | US FAERS | |
| 80 | Depressed Level of Consciousness | FAERS: 5 | US FAERS | |
| 81 | Discomfort | FAERS: 5 | US FAERS | |
| 82 | Injection site erythema | FAERS: 5 | US FAERS | |
| 83 | Lethargy | FAERS: 5 | US FAERS | |
| 84 | Paranoia | FAERS: 5 | US FAERS | |
| 85 | Quality of life decreased | FAERS: 5 | US FAERS | |
| 86 | Stevens-Johnson Syndrome | FAERS: 5 | US FAERS | |
| 87 | Anger | FAERS: 4 | US FAERS | |
| 88 | Angioedema | FAERS: 4 | US FAERS | |
| 89 | Blepharospasm | FAERS: 4 | US FAERS | |
| 90 | Blindness | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 91 | Bursitis | FAERS: 4 | US FAERS | |
| 92 | Cartilage injury | FAERS: 4 | US FAERS | |
| 93 | Deafness | FAERS: 4 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 94 | Dyslalia | FAERS: 4 | US FAERS | |
| 95 | Ear discomfort | FAERS: 4 | US FAERS | |
| 96 | Emotional distress | FAERS: 4 | US FAERS | |
| 97 | Enamel anomaly | FAERS: 4 | US FAERS | |
| 98 | Hyperacusis | FAERS: 4 | US FAERS | |
| 99 | Hypotension | FAERS: 4 | US FAERS | |
| 100 | Myoclonus | FAERS: 4 | US FAERS | |
| 101 | Peripheral swelling | FAERS: 4 | US FAERS | |
| 102 | Petechiae | FAERS: 4 | US FAERS | |
| 103 | Pharmaceutical product complaint | FAERS: 4 | US FAERS | |
| 104 | Poisoning | FAERS: 4 | US FAERS | |
| 105 | Skin Ulcer | FAERS: 4 | US FAERS | |
| 106 | Superficial vein prominence | FAERS: 4 | US FAERS | |
| 107 | Tachycardia | FAERS: 4 | US FAERS | |
| 108 | Vitreous floaters | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 109 | Wheelchair user | FAERS: 4 | US FAERS | |
| 110 | Wheezing | FAERS: 4 | US FAERS | |
| 111 | Alopecia | FAERS: 3 | US FAERS | |
| 112 | Autoimmune hepatitis | FAERS: 3 | US FAERS | |
| 113 | Blood creatine phosphokinase increased | FAERS: 3 | US FAERS | |
| 114 | Drug exposure during pregnancy | FAERS: 3 | US FAERS | |
| 115 | Drug resistance | FAERS: 3 | US FAERS | |
| 116 | Dysphonia | FAERS: 3 | US FAERS | |
| 117 | Dystonia | FAERS: 3 | US FAERS | |
| 118 | Economic problem | FAERS: 3 | US FAERS | |
| 119 | Eye irritation | FAERS: 3 | US FAERS | |
| 120 | Fibromyalgia | FAERS: 3 | US FAERS | |
| 121 | Hemiparesis | FAERS: 3 | US FAERS | |
| 122 | Hepatitis | FAERS: 3 | US FAERS | |
| 123 | Impaired driving ability | FAERS: 3 | US FAERS | |
| 124 | Injection Site Reaction | FAERS: 3 | US FAERS | |
| 125 | Mental impairment | FAERS: 3 | US FAERS | |
| 126 | Mental status changes | FAERS: 3 | US FAERS | |
| 127 | Middle insomnia | FAERS: 3 | US FAERS | |
| 128 | Muscle strain | FAERS: 3 | US FAERS | |
| 129 | Musculoskeletal chest pain | FAERS: 3 | US FAERS | |
| 130 | Neutropenia | FAERS: 3 | US FAERS | |
| 131 | Pancreatitis | FAERS: 3 | US FAERS | |
| 132 | Product quality issue | FAERS: 3 | US FAERS | |
| 133 | Pyelonephritis | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 134 | Rash erythematous | FAERS: 3 | US FAERS | |
| 135 | Renal tubular necrosis | FAERS: 3 | US FAERS | |
| 136 | Rhabdomyolysis | FAERS: 3 | US FAERS | |
| 137 | Somnolence | FAERS: 3 | US FAERS | |
| 138 | Stomatitis | FAERS: 3 | US FAERS | |
| 139 | Stress | FAERS: 3 | US FAERS | |
| 140 | Thrombocytopenia | FAERS: 3 | US FAERS | |
| 141 | Toothache | FAERS: 3 | US FAERS | |
| 142 | jaundice | FAERS: 3 | US FAERS | |
| 143 | Adverse event | FAERS: 2 | US FAERS | |
| 144 | Amnesia | FAERS: 2 | US FAERS | |
| 145 | Anal Fissure | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 146 | Anal abscess | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 147 | Anhedonia | FAERS: 2 | US FAERS | |
| 148 | Ankle Fracture | FAERS: 2 | US FAERS | |
| 149 | Anosmia | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 150 | Antiphospholipid Antibodies | FAERS: 2 | US FAERS | |
| 151 | Aphasia | FAERS: 2 | US FAERS | |
| 152 | Apparent death | FAERS: 2 | US FAERS | |
| 153 | Asthma | FAERS: 2 | US FAERS | |
| 154 | Ataxia | FAERS: 2 | US FAERS | |
| 155 | Bedridden | FAERS: 2 | US FAERS | |
| 156 | Blood blister | FAERS: 2 | US FAERS | |
| 157 | Blood urine present | FAERS: 2 | US FAERS | |
| 158 | Carpal Tunnel Syndrome | FAERS: 2 | US FAERS | |
| 159 | Cellulitis | FAERS: 2 | US FAERS | |
| 160 | Chromaturia | FAERS: 2 | US FAERS | |
| 161 | Chronic Fatigue Syndrome | FAERS: 2 | US FAERS | |
| 162 | Cogwheel Rigidity | FAERS: 2 | US FAERS | |
| 163 | Cold sweat | FAERS: 2 | US FAERS | |
| 164 | Colectomy | FAERS: 2 | US FAERS | |
| 165 | Cystitis | FAERS: 2 | US FAERS | |
| 166 | Deformity | FAERS: 2 | US FAERS | |
| 167 | Diplopia | FAERS: 2 | US FAERS | |
| 168 | Disability | FAERS: 2 | US FAERS | |
| 169 | Diverticulitis | FAERS: 2 | US FAERS | |
| 170 | Dry skin | FAERS: 2 | US FAERS | |
| 171 | Dysarthria | FAERS: 2 | US FAERS | |
| 172 | Eczema | FAERS: 2 | US FAERS | |
| 173 | Enteritis | FAERS: 2 | US FAERS | |
| 174 | Epidermal necrosis | FAERS: 2 | US FAERS | |
| 175 | Extravasation | FAERS: 2 | US FAERS | |
| 176 | Facial Pain | FAERS: 2 | US FAERS | |
| 177 | Factor V inhibition | FAERS: 2 | US FAERS | |
| 178 | Head discomfort | FAERS: 2 | US FAERS | |
| 179 | Hepatotoxicity | FAERS: 2 | US FAERS | |
| 180 | Hypoaesthesia facial | FAERS: 2 | US FAERS | |
| 181 | Hypokinesia | FAERS: 2 | US FAERS | |
| 182 | Hypophagia | FAERS: 2 | US FAERS | |
| 183 | Hypothyroidism | FAERS: 2 | US FAERS | |
| 184 | Incision site complication | FAERS: 2 | US FAERS | |
| 185 | Incorrect dose administered | FAERS: 2 | US FAERS | |
| 186 | Infection | FAERS: 2 | US FAERS | |
| 187 | Injection site pain | FAERS: 2 | US FAERS | |
| 188 | Joint Instability | FAERS: 2 | US FAERS | |
| 189 | Limb injury | FAERS: 2 | US FAERS | |
| 190 | Lip swelling | FAERS: 2 | US FAERS | |
| 191 | Lipase increased | FAERS: 2 | US FAERS | |
| 192 | Malacoplakia gastrointestinal | FAERS: 2 | US FAERS | |
| 193 | Mental Fatigue | FAERS: 2 | US FAERS | |
| 194 | Myositis | FAERS: 2 | US FAERS | |
| 195 | Night sweats | FAERS: 2 | US FAERS | |
| 196 | Nystagmus | FAERS: 2 | US FAERS | |
| 197 | Oropharyngeal pain | FAERS: 2 | US FAERS | |
| 198 | Osteitis | FAERS: 2 | US FAERS | |
| 199 | Osteopenia | FAERS: 2 | US FAERS | |
| 200 | Pallor | FAERS: 2 | US FAERS | |
| 201 | Papule | FAERS: 2 | US FAERS | |
| 202 | Pathogen resistance | FAERS: 2 | US FAERS | |
| 203 | Pelvic Pain | FAERS: 2 | US FAERS | |
| 204 | Performance status decreased | FAERS: 2 | US FAERS | |
| 205 | Poor quality sleep | FAERS: 2 | US FAERS | |
| 206 | Product taste abnormal | FAERS: 2 | US FAERS | |
| 207 | Pulmonary Embolism | FAERS: 2 | US FAERS | |
| 208 | Purpura | FAERS: 2 | US FAERS | |
| 209 | Renal tubular disorder | FAERS: 2 | US FAERS | |
| 210 | Respiratory Failure | FAERS: 2 | US FAERS | |
| 211 | Retinal Detachment | FAERS: 2 | US FAERS | |
| 212 | Skin Wrinkling | FAERS: 2 | US FAERS | |
| 213 | Sleep disorder due to general medical condition, insomnia type | FAERS: 2 | US FAERS | |
| 214 | Splenectomy | FAERS: 2 | US FAERS | |
| 215 | Sudden onset of sleep | FAERS: 2 | US FAERS | |
| 216 | Synovitis | FAERS: 2 | US FAERS | |
| 217 | Therapy non-responder | FAERS: 2 | US FAERS | |
| 218 | Thermal burn | FAERS: 2 | US FAERS | |
| 219 | Thrombophlebitis | FAERS: 2 | US FAERS | |
| 220 | Urinary Retention | FAERS: 2 | US FAERS | |
| 221 | Vitamin K Deficiency | FAERS: 2 | US FAERS | |
| 222 | Abdominal tenderness | FAERS: 1 | US FAERS | |
| 223 | Abnormal palmar/plantar creases | FAERS: 1 | US FAERS | |
| 224 | Acarodermatitis | FAERS: 1 | US FAERS | |
| 225 | Acute Motor Axonal Neuropathy | FAERS: 1 | US FAERS | |
| 226 | Acute kidney injury | FAERS: 1 | US FAERS | |
| 227 | Altered state of consciousness | FAERS: 1 | US FAERS | |
| 228 | Altered visual depth perception | FAERS: 1 | US FAERS | |
| 229 | Ammonia increased | FAERS: 1 | US FAERS | |
| 230 | Anaphylactic shock | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 231 | Angina Pectoris | FAERS: 1 | US FAERS | |
| 232 | Anorectal discomfort | FAERS: 1 | US FAERS | |
| 233 | Anorexia | FAERS: 1 | US FAERS | |
| 234 | Antibody test abnormal | FAERS: 1 | US FAERS | |
| 235 | Antibody test positive | FAERS: 1 | US FAERS | |
| 236 | Aortic Aneurysm | FAERS: 1 | US FAERS | |
| 237 | Aphagia | FAERS: 1 | US FAERS | |
| 238 | Appendicitis | FAERS: 1 | US FAERS | |
| 239 | Arthropod bite | FAERS: 1 | US FAERS | |
| 240 | Asterixis | FAERS: 1 | US FAERS | |
| 241 | Atrioventricular Block | FAERS: 1 | US FAERS | |
| 242 | Autoimmune neuropathy | FAERS: 1 | US FAERS | |
| 243 | Axonal neuropathy | FAERS: 1 | US FAERS | |
| 244 | Belligerence | FAERS: 1 | US FAERS | |
| 245 | Bladder pain | FAERS: 1 | US FAERS | |
| 246 | Blood albumin abnormal | FAERS: 1 | US FAERS | |
| 247 | Blood albumin decreased | FAERS: 1 | US FAERS | |
| 248 | Blood glucose decreased | FAERS: 1 | US FAERS | |
| 249 | Blood potassium decreased | FAERS: 1 | US FAERS | |
| 250 | Blood pressure inadequately controlled | FAERS: 1 | US FAERS | |
| 251 | Bradyphrenia | FAERS: 1 | US FAERS | |
| 252 | Breast tenderness | FAERS: 1 | US FAERS | |
| 253 | Candidiasis | FAERS: 1 | US FAERS | |
| 254 | Cartilage atrophy | FAERS: 1 | US FAERS | |
| 255 | Cell Death | FAERS: 1 | US FAERS | |
| 256 | Cerebral Thrombosis | FAERS: 1 | US FAERS | |
| 257 | Cerebral disorder | FAERS: 1 | US FAERS | |
| 258 | Choking sensation | FAERS: 1 | US FAERS | |
| 259 | Cholestasis | FAERS: 1 | US FAERS | |
| 260 | Chorea | FAERS: 1 | US FAERS | |
| 261 | Clostridium test positive | FAERS: 1 | US FAERS | |
| 262 | Completed Suicide | FAERS: 1 | US FAERS | |
| 263 | Conversion disorder | FAERS: 1 | US FAERS | |
| 264 | Crystal nephropathy | FAERS: 1 | US FAERS | |
| 265 | Crystal urine present | FAERS: 1 | US FAERS | |
| 266 | Cyanosis | FAERS: 1 | US FAERS | |
| 267 | Delirium | FAERS: 1 | US FAERS | |
| 268 | Dementia | FAERS: 1 | US FAERS | |
| 269 | Dental discomfort | FAERS: 1 | US FAERS | |
| 270 | Depressed mood | FAERS: 1 | US FAERS | |
| 271 | Depression suicidal | FAERS: 1 | US FAERS | |
| 272 | Dermatitis | FAERS: 1 | US FAERS | |
| 273 | Disease recurrence | FAERS: 1 | US FAERS | |
| 274 | Dissociative disorder | FAERS: 1 | US FAERS | |
| 275 | Documented hypersensitivity to administered product | FAERS: 1 | US FAERS | |
| 276 | Drug clearance decreased | FAERS: 1 | US FAERS | |
| 277 | Drug dose omission | FAERS: 1 | US FAERS | |
| 278 | Drug prescribing error | FAERS: 1 | US FAERS | |
| 279 | Drug screen positive | FAERS: 1 | US FAERS | |
| 280 | Dysacusis | FAERS: 1 | US FAERS | |
| 281 | Dyscalculia | FAERS: 1 | US FAERS | |
| 282 | Dysentery | FAERS: 1 | US FAERS | |
| 283 | Dysgraphia | FAERS: 1 | US FAERS | |
| 284 | Dyslexia | FAERS: 1 | US FAERS | |
| 285 | Dysuria | FAERS: 1 | US FAERS | |
| 286 | Ear congestion | FAERS: 1 | US FAERS | |
| 287 | Ecchymosis | FAERS: 1 | US FAERS | |
| 288 | Enthesopathy | FAERS: 1 | US FAERS | |
| 289 | Enuresis | FAERS: 1 | US FAERS | |
| 290 | Eosinophilia | FAERS: 1 | US FAERS | |
| 291 | Epicondylitis | FAERS: 1 | US FAERS | |
| 292 | Epidermolysis | FAERS: 1 | US FAERS | |
| 293 | Erectile dysfunction | FAERS: 1 | US FAERS | |
| 294 | Eructation | FAERS: 1 | US FAERS | |
| 295 | Erythema Multiforme | FAERS: 1 | US FAERS | |
| 296 | Erythema Nodosum | FAERS: 1 | US FAERS | |
| 297 | Expired drug administered | FAERS: 1 | US FAERS | |
| 298 | Eye Infection | FAERS: 1 | US FAERS | |
| 299 | Eye inflammation | FAERS: 1 | US FAERS | |
| 300 | Factor VIII inhibition | FAERS: 1 | US FAERS | |
| 301 | Factor XIII Inhibition | FAERS: 1 | US FAERS | |
| 302 | Fasciitis | FAERS: 1 | US FAERS | |
| 303 | Flank Pain | FAERS: 1 | US FAERS | |
| 304 | Flatulence | FAERS: 1 | US FAERS | |
| 305 | Fluid imbalance | FAERS: 1 | US FAERS | |
| 306 | Fluid overload | FAERS: 1 | US FAERS | |
| 307 | Foreign body aspiration | FAERS: 1 | US FAERS | |
| 308 | Foreign body sensation in eyes | FAERS: 1 | US FAERS | |
| 309 | Formication | FAERS: 1 | US FAERS | |
| 310 | Frustration | FAERS: 1 | US FAERS | |
| 311 | Gangrene | FAERS: 1 | US FAERS | |
| 312 | Gastric infection | FAERS: 1 | US FAERS | |
| 313 | Gastrointestinal Pain | FAERS: 1 | US FAERS | |
| 314 | Gastrointestinal toxicity | FAERS: 1 | US FAERS | |
| 315 | Gingivitis | FAERS: 1 | US FAERS | |
| 316 | Glossitis | FAERS: 1 | US FAERS | |
| 317 | Guillain-Barre Syndrome | FAERS: 1 | US FAERS | |
| 318 | Hernia | FAERS: 1 | US FAERS | |
| 319 | Hypothalamic pituitary adrenal axis suppression | FAERS: 1 | US FAERS | |
| 320 | Hypothalamo-pituitary disorder | FAERS: 1 | US FAERS | |
| 321 | Ileus | FAERS: 1 | US FAERS | |
| 322 | Immobile | FAERS: 1 | US FAERS | |
| 323 | Immune thrombocytopenic purpura | FAERS: 1 | US FAERS | |
| 324 | Inadequate analgesia | FAERS: 1 | US FAERS | |
| 325 | Incision site erythema | FAERS: 1 | US FAERS | |
| 326 | Incision site pain | FAERS: 1 | US FAERS | |
| 327 | Incorrect route of drug administration | FAERS: 1 | US FAERS | |
| 328 | Increased tendency to bruise | FAERS: 1 | US FAERS | |
| 329 | Infusion Site Extravasation | FAERS: 1 | US FAERS | |
| 330 | Infusion site erythema | FAERS: 1 | US FAERS | |
| 331 | Infusion site rash | FAERS: 1 | US FAERS | |
| 332 | Infusion site swelling | FAERS: 1 | US FAERS | |
| 333 | Initial insomnia | FAERS: 1 | US FAERS | |
| 334 | Injection site extravasation | FAERS: 1 | US FAERS | |
| 335 | Injection site pruritus | FAERS: 1 | US FAERS | |
| 336 | Internal injury | FAERS: 1 | US FAERS | |
| 337 | Irritable Bowel Syndrome | FAERS: 1 | US FAERS | |
| 338 | Joint sprain | FAERS: 1 | US FAERS | |
| 339 | Labyrinthitis | FAERS: 1 | US FAERS | |
| 340 | Ligament pain | FAERS: 1 | US FAERS | |
| 341 | Limb discomfort | FAERS: 1 | US FAERS | |
| 342 | Loose tooth | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 343 | Loss of personal independence in daily activities | FAERS: 1 | US FAERS | |
| 344 | Lumbar puncture abnormal | FAERS: 1 | US FAERS | |
| 345 | Lymphadenopathy | FAERS: 1 | US FAERS | |
| 346 | Macrocytosis | FAERS: 1 | US FAERS | |
| 347 | Malabsorption | FAERS: 1 | US FAERS | |
| 348 | Medication residue | FAERS: 1 | US FAERS | |
| 349 | Meningitis | FAERS: 1 | US FAERS | |
| 350 | Mononeuritis | FAERS: 1 | US FAERS | |
| 351 | Multi-organ disorder | FAERS: 1 | US FAERS | |
| 352 | Multiple Chemical Sensitivity | FAERS: 1 | US FAERS | |
| 353 | Muscle Fatigue | FAERS: 1 | US FAERS | |
| 354 | Myopathy | FAERS: 1 | US FAERS | |
| 355 | Nasal pruritus | FAERS: 1 | US FAERS | |
| 356 | Nasopharyngitis | FAERS: 1 | US FAERS | |
| 357 | Nephrotic Syndrome | FAERS: 1 | US FAERS | |
| 358 | Neuropathy | FAERS: 1 | US FAERS | |
| 359 | No reaction on previous exposure to drug | FAERS: 1 | US FAERS | |
| 360 | Nodule | FAERS: 1 | US FAERS | |
| 361 | Ocular vascular disorder | FAERS: 1 | US FAERS | |
| 362 | Oliguria | FAERS: 1 | US FAERS | |
| 363 | Onychoclasis | FAERS: 1 | US FAERS | |
| 364 | Optic Neuropathy | FAERS: 1 | US FAERS | |
| 365 | Optic nerve infarction | FAERS: 1 | US FAERS | |
| 366 | Oral candidiasis | FAERS: 1 | US FAERS | |
| 367 | Oral pain | FAERS: 1 | US FAERS | |
| 368 | Orthosis user | FAERS: 1 | US FAERS | |
| 369 | Osteochondrosis | FAERS: 1 | US FAERS | |
| 370 | Osteomyelitis | FAERS: 1 | US FAERS | |
| 371 | Oxygen saturation abnormal | FAERS: 1 | US FAERS | |
| 372 | Panic Disorder | FAERS: 1 | US FAERS | |
| 373 | Paranasal sinus discomfort | FAERS: 1 | US FAERS | |
| 374 | Periarthritis | FAERS: 1 | US FAERS | |
| 375 | Peripheral motor neuropathy | FAERS: 1 | US FAERS | |
| 376 | Peripheral paralysis | FAERS: 1 | US FAERS | |
| 377 | Pharyngeal erosion | FAERS: 1 | US FAERS | |
| 378 | Pigmentation lip | FAERS: 1 | US FAERS | |
| 379 | Pneumatosis intestinalis | FAERS: 1 | US FAERS | |
| 380 | Pneumonia | FAERS: 1 | US FAERS | |
| 381 | Polyarthritis | FAERS: 1 | US FAERS | |
| 382 | Polydipsia | FAERS: 1 | US FAERS | |
| 383 | Poor quality drug administered | FAERS: 1 | US FAERS | |
| 384 | Post-traumatic neck syndrome | FAERS: 1 | US FAERS | |
| 385 | Premenstrual syndrome | FAERS: 1 | US FAERS | |
| 386 | Product formulation issue | FAERS: 1 | US FAERS | |
| 387 | Product measured potency issue | FAERS: 1 | US FAERS | |
| 388 | Prothrombin level decreased | FAERS: 1 | US FAERS | |
| 389 | Prurigo | FAERS: 1 | US FAERS | |
| 390 | Pulmonary Eosinophilia | FAERS: 1 | US FAERS | |
| 391 | Pulmonary thrombosis | FAERS: 1 | US FAERS | |
| 392 | Radiculopathy | FAERS: 1 | US FAERS | |
| 393 | Reaction to drug excipients | FAERS: 1 | US FAERS | |
| 394 | Renal pain | FAERS: 1 | US FAERS | |
| 395 | Respiratory Depression | FAERS: 1 | US FAERS | |
| 396 | Respiratory arrest | FAERS: 1 | US FAERS | |
| 397 | Respiratory distress | FAERS: 1 | US FAERS | |
| 398 | Restrictive pulmonary disease | FAERS: 1 | US FAERS | |
| 399 | Rheumatoid Arthritis | FAERS: 1 | US FAERS | |
| 400 | Rhinalgia | FAERS: 1 | US FAERS | |
| 401 | Right ventricular failure | FAERS: 1 | US FAERS | |
| 402 | Scab | FAERS: 1 | US FAERS | |
| 403 | Sciatica | FAERS: 1 | US FAERS | |
| 404 | Screaming | FAERS: 1 | US FAERS | |
| 405 | Self-induced vomiting | FAERS: 1 | US FAERS | |
| 406 | Sepsis | FAERS: 1 | US FAERS | |
| 407 | Serum Sickness | FAERS: 1 | US FAERS | |
| 408 | Sneezing | FAERS: 1 | US FAERS | |
| 409 | Soft tissue necrosis | FAERS: 1 | US FAERS | |
| 410 | Splenic abscess | FAERS: 1 | US FAERS | |
| 411 | Squamous cell carcinoma of skin | FAERS: 1 | US FAERS | |
| 412 | Strabismus | FAERS: 1 | US FAERS | |
| 413 | Subcutaneous Abscess | FAERS: 1 | US FAERS | |
| 414 | Tachyphrenia | FAERS: 1 | US FAERS | |
| 415 | Temperature intolerance | FAERS: 1 | US FAERS | |
| 416 | Temperature regulation disorder | FAERS: 1 | US FAERS | |
| 417 | Tendon discomfort | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 418 | Tenosynovitis | FAERS: 1 | US FAERS | |
| 419 | Tension Headache | FAERS: 1 | US FAERS | |
| 420 | Therapeutic response unexpected | FAERS: 1 | US FAERS | |
| 421 | Therapy cessation | FAERS: 1 | US FAERS | |
| 422 | Throat irritation | FAERS: 1 | US FAERS | |
| 423 | Tongue biting | FAERS: 1 | US FAERS | |
| 424 | Tonsillitis | FAERS: 1 | US FAERS | |
| 425 | Torticollis | FAERS: 1 | US FAERS | |
| 426 | Toxic Epidermal Necrolysis | FAERS: 1 | US FAERS | |
| 427 | Ulcer | FAERS: 1 | US FAERS | |
| 428 | Urinary Incontinence | FAERS: 1 | US FAERS | |
| 429 | Urine viscosity increased | FAERS: 1 | US FAERS | |
| 430 | Vanishing bile duct syndrome | FAERS: 1 | US FAERS | |
| 431 | Vascular purpura | FAERS: 1 | US FAERS | |
| 432 | Violence-related symptom | FAERS: 1 | US FAERS | |
| 433 | Visceral Pain | FAERS: 1 | US FAERS | |
| 434 | Visual brightness | FAERS: 1 | US FAERS | |
| 435 | Visual disturbance | FAERS: 1 | US FAERS | |
| 436 | Vulvovaginal mycotic infection | FAERS: 1 | US FAERS | |
| 437 | Vulvovaginal pruritus | FAERS: 1 | US FAERS | |
| 438 | White blood cell count decreased | FAERS: 1 | US FAERS | |
| 439 | Wound dehiscence | FAERS: 1 | US FAERS | |
| 440 | muscle injury | FAERS: 1 | US FAERS | |
| 441 | Clostridium difficile infection | Canada Vigilance: 1 | Canada Vigilance | |
| 442 | Phimosis | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.